Reuters was first to report that SoftBankâ€™s Vision Fund 2 was leading a $250 million investment in Silicon Valley-based startup Alto Pharmacy. SoftBankâ€™s Vision Fund II contributed a majority of the funding round. At one point, the fund considered investing as much as $300 million but eventually decided to limit its exposure. Other existing investors in Alto, including Greenoaks Capital and Jackson Square Ventures, also participated in the Series D round.
Reuters first to report SoftBank leads latest Alto Pharmacy funding round
30 January 2020, 12:00 am 1 minute
More of Reuters Best
September 04, 2023
August 28, 2023